Kymera Therapeutics (KYMR) Return on Equity [ROE] (2020 - 2026)
Kymera Therapeutics' Return on Equity [ROE] came in at -22.97% for Q2 2026, up 12.51 percentage points from -35.48% a year earlier and up 0.06 percentage points from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Kymera Therapeutics' Return on Equity [ROE] was -28.93%, up 13.59 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +15.28 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -42.52% in FY2024 (-5.12 pp), -37.40% in FY2023 (-3.45 pp), -33.96% in FY2022 (-6.91 pp) and -27.04% in FY2021 (+17.17 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q4 2021.
- Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +4.60 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 26.95 percentage points), and the weakest in Q3 2022 (a drop of 12.99 percentage points).
- Business Quant data shows KYMR's Return on Equity [ROE] at -23.03% (Q1 2026), -27.67% (Q4 2025) and -34.65% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Kymera Therapeutics | 8.89 Bn | 6.19 Bn | - | -22.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.97% |
| Mar 31, 2026 | -23.03% |
| Dec 31, 2025 | -27.67% |
| Sep 30, 2025 | -34.65% |
| Jun 30, 2025 | -35.48% |
| Mar 31, 2025 | -34.31% |
| Dec 31, 2024 | -30.27% |
| Sep 30, 2024 | -25.38% |
| Jun 30, 2024 | -26.58% |
| Mar 31, 2024 | -32.19% |
| Dec 31, 2023 | -41.88% |
| Sep 30, 2023 | -44.49% |
| Jun 30, 2023 | -38.38% |
| Mar 31, 2023 | -35.63% |
| Dec 31, 2022 | -32.15% |
| Sep 30, 2022 | -34.39% |
| Jun 30, 2022 | -33.96% |
| Mar 31, 2022 | -27.98% |
| Dec 31, 2021 | -21.33% |
| Sep 30, 2021 | -21.40% |
API Access
Kymera Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();